Takayoshi Watanabe

1.6k total citations
89 papers, 1.2k citations indexed

About

Takayoshi Watanabe is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Takayoshi Watanabe has authored 89 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Molecular Biology, 26 papers in Oncology and 19 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Takayoshi Watanabe's work include Gastric Cancer Management and Outcomes (15 papers), RNA and protein synthesis mechanisms (11 papers) and Advanced biosensing and bioanalysis techniques (10 papers). Takayoshi Watanabe is often cited by papers focused on Gastric Cancer Management and Outcomes (15 papers), RNA and protein synthesis mechanisms (11 papers) and Advanced biosensing and bioanalysis techniques (10 papers). Takayoshi Watanabe collaborates with scholars based in Japan, United States and Germany. Takayoshi Watanabe's co-authors include Hiroshi Sugiyama, Hiroki Nagase, Toshiaki Furuta, Takahiro Hohsaka, Ryu Tashiro, Michiko Iwamura, Toshikazu Bando, Noboru Fukuda, Nobuko Koshikawa and Megumi Ishii and has published in prestigious journals such as Journal of the American Chemical Society, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Takayoshi Watanabe

82 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Takayoshi Watanabe Japan 17 717 239 237 167 101 89 1.2k
Christophe Antczak United States 21 592 0.8× 198 0.8× 178 0.8× 305 1.8× 72 0.7× 44 1.3k
Qing Lin United States 23 1.9k 2.6× 119 0.5× 231 1.0× 121 0.7× 76 0.8× 42 2.4k
Sara Pellegrino Italy 24 923 1.3× 110 0.5× 585 2.5× 129 0.8× 43 0.4× 124 1.7k
Jérôme Devy France 17 551 0.8× 269 1.1× 108 0.5× 173 1.0× 38 0.4× 43 1.2k
E. V. Rusinova Russia 19 1.4k 1.9× 125 0.5× 85 0.4× 225 1.3× 48 0.5× 72 1.8k
Rajan R. Dighe India 25 615 0.9× 312 1.3× 304 1.3× 643 3.9× 36 0.4× 56 1.6k
Bixing Zhao China 23 633 0.9× 156 0.7× 142 0.6× 246 1.5× 142 1.4× 62 1.5k
Wei Lin China 23 925 1.3× 62 0.3× 232 1.0× 169 1.0× 105 1.0× 69 1.5k
Elena A. Dubikovskaya Switzerland 15 602 0.8× 128 0.5× 148 0.6× 79 0.5× 69 0.7× 23 1.3k
Jolene A. Bradford United States 12 608 0.8× 84 0.4× 112 0.5× 159 1.0× 26 0.3× 41 1.1k

Countries citing papers authored by Takayoshi Watanabe

Since Specialization
Citations

This map shows the geographic impact of Takayoshi Watanabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takayoshi Watanabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takayoshi Watanabe more than expected).

Fields of papers citing papers by Takayoshi Watanabe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takayoshi Watanabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takayoshi Watanabe. The network helps show where Takayoshi Watanabe may publish in the future.

Co-authorship network of co-authors of Takayoshi Watanabe

This figure shows the co-authorship network connecting the top 25 collaborators of Takayoshi Watanabe. A scholar is included among the top collaborators of Takayoshi Watanabe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takayoshi Watanabe. Takayoshi Watanabe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Watanabe, Takayoshi, et al.. (2026). A universal polyphosphate kinase powers in vitro transcription. Nature Communications. 17(1). 1252–1252.
2.
Masuda, Tatsuya, Takayoshi Watanabe, Yasutoshi Tatsumi, et al.. (2025). Cancer Accumulation and Anticancer Activity of “CROX (Cluster Regulation of RUNX)” PIP in HER2‐Positive Gastric Cancer Evaluated by Chicken Egg Cancer Model. Cancer Medicine. 14(7). e70845–e70845.
3.
Nakazawa, Nobuhiro, Makoto Sohda, Mizuki Endo, et al.. (2024). The Gustave Roussy Immune score is a powerful biomarker for predicting therapeutic resistance to chemotherapy in gastric cancer patients. Cancer Chemotherapy and Pharmacology. 94(4). 517–522.
4.
Sakai, Makoto, Makoto Sohda, Takayoshi Watanabe, et al.. (2024). Efficacy of thoracic endovascular aortic repair for aorto-esophageal fistula due to esophageal cancer: a systematic review and meta-analysis. Esophagus. 21(2). 95–101. 2 indexed citations
5.
Nakazawa, Nobuhiro, Takehiko Yokobori, Makoto Sohda, et al.. (2023). Significance of Lipopolysaccharides in Gastric Cancer and Their Potential as a Biomarker for Nivolumab Sensitivity. International Journal of Molecular Sciences. 24(14). 11790–11790. 4 indexed citations
6.
Nakazawa, Nobuhiro, Makoto Sohda, Ayaka Katayama, et al.. (2023). Infiltration of Gastric Cancer Stroma by Tumor-Infiltrating Lymphocytes Correlates with Mechanistic Target of Rapamycin Signaling. Oncology. 101(8). 520–526. 1 indexed citations
7.
Nakazawa, Nobuhiro, Makoto Sohda, Takayoshi Watanabe, et al.. (2023). Albumin–derived Neutrophil-to-Lymphocyte Ratio Score as a Marker of Nivolumab Treatment Sensitivity in Gastric Cancer: A Multicenter Study. In Vivo. 37(2). 818–824. 4 indexed citations
8.
Sano, Akihiko, Makoto Sohda, Takayoshi Watanabe, et al.. (2023). Importance of Progression-free Survival in Second-line Chemotherapy in Patients With Advanced or Recurrent Gastric Cancer. Anticancer Research. 43(11). 5205–5213. 1 indexed citations
9.
Sakai, Makoto, Makoto Sohda, Takayoshi Watanabe, et al.. (2021). Fibrin/fibrinogen Degradation Products Are Associated With Tumor Stage and Prognosis in Patients Undergoing Resection of Esophageal Cancer. Anticancer Research. 41(9). 4523–4527. 4 indexed citations
10.
Koshikawa, Nobuko, Kohei Tsuji, Takayoshi Watanabe, et al.. (2021). A linear five-ring pyrrole-imidazole polyamide-triphenylphosphonium conjugate targeting a mitochondrial DNA mutation efficiently induces apoptosis of HeLa cybrid cells carrying the mutation. Biochemical and Biophysical Research Communications. 576. 93–99. 7 indexed citations
11.
Okumura, Kazuhiro, Takayoshi Watanabe, Yoshihiro Kodama, et al.. (2019). Enrichment technique to allow early detection and monitor emergence of KRAS mutation in response to treatment. Scientific Reports. 9(1). 11346–11346. 9 indexed citations
12.
Yoda, Hiroyuki, Takahiro Inoue, Jason Lin, et al.. (2018). Direct Targeting of MYCN Gene Amplification by Site-Specific DNA Alkylation in Neuroblastoma. Cancer Research. 79(4). 830–840. 31 indexed citations
13.
Fukunaga, Keisuke, et al.. (2018). Antigen-responsive fluorescent antibody probes generated by selective N-terminal modification of IgGs. Chemical Communications. 54(90). 12734–12737. 14 indexed citations
14.
Shinohara, Ken‐ichi, Takayoshi Watanabe, Masaki Fukuyo, et al.. (2016). Inhibition of DNA Methylation at the MLH1 Promoter Region Using Pyrrole–Imidazole Polyamide. ACS Omega. 1(6). 1164–1172. 6 indexed citations
15.
Tokuda, Yasunori, et al.. (2011). Biosynthesis of proteins containing modified lysines and fluorescent labels using non-natural amino acid mutagenesis. Journal of Bioscience and Bioengineering. 111(4). 402–407. 8 indexed citations
16.
Matsuda, Hiroyuki, Noboru Fukuda, Takahiro Ueno, et al.. (2010). Transcriptional inhibition of progressive renal disease by gene silencing pyrrole–imidazole polyamide targeting of the transforming growth factor-β1 promoter. Kidney International. 79(1). 46–56. 63 indexed citations
17.
Suzuki, Tsukasa, Yukihiro Asami, Teruyuki Takahashi, et al.. (2009). Development of a molecule-recognized promoter DNA sequence for inhibition of HER2 expression. The Journal of Antibiotics. 62(6). 339–341. 5 indexed citations
18.
Imai, Shinobu, Takayoshi Watanabe, Naoyuki Takahashi, et al.. (2002). Localization of Sinus Nodal Impulset : Sinus Node Electrograms Mapping Guided by Intracardiac Echocardiography. Japanese Circulation Journal-english Edition. 66. 450. 2 indexed citations
19.
Saito, Fumio, Masamitsu Nakazato, Haruhiko Akiyama, et al.. (2001). A case of late onset cardiac amyloidosis with a new transthyretin variant (Lysine 92). Human Pathology. 32(2). 237–239. 8 indexed citations
20.
Sato, Atsuhiko, et al.. (1988). T-3262 in respiratory tract infections. Chemotherapy. 36(9). 555–566. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christophe Antczak Breakdown of academic impact, for papers by Qing Lin Breakdown of academic impact, for papers by Sara Pellegrino Breakdown of academic impact, for papers by Jérôme Devy Breakdown of academic impact, for papers by E. V. Rusinova Breakdown of academic impact, for papers by Rajan R. Dighe Breakdown of academic impact, for papers by Bixing Zhao Breakdown of academic impact, for papers by Wei Lin Breakdown of academic impact, for papers by Elena A. Dubikovskaya Breakdown of academic impact, for papers by Jolene A. Bradford
Rankless by CCL
2026